Page last updated: 2024-10-26

3,3'-diindolylmethane and Carcinoma, Ductal, Pancreatic

3,3'-diindolylmethane has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Research Excerpts

ExcerptRelevanceReference
"The aggressive course of pancreatic cancer is believed to reflect its unusually invasive and metastatic nature, which is associated with epidermal growth factor receptor (EGFR) overexpression and NF-kappaB activation."1.36miR-146a suppresses invasion of pancreatic cancer cells. ( Ali, S; Kong, D; Li, Y; Philip, PA; Sarkar, FH; Vandenboom, TG; Wang, Z, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Y1
Vandenboom, TG1
Wang, Z1
Kong, D1
Ali, S1
Philip, PA1
Sarkar, FH1
Hong, J1
Samudio, I1
Liu, S1
Abdelrahim, M1
Safe, S1

Other Studies

2 other studies available for 3,3'-diindolylmethane and Carcinoma, Ductal, Pancreatic

ArticleYear
miR-146a suppresses invasion of pancreatic cancer cells.
    Cancer research, 2010, Feb-15, Volume: 70, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cells, Cultured; Drug Evaluation, Preclinical;

2010
Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins.
    Endocrinology, 2004, Volume: 145, Issue:12

    Topics: Anticarcinogenic Agents; Carcinoma, Pancreatic Ductal; Cell Cycle Proteins; Cell Division; Cell Line

2004